Assess whether umbrella attachment is too thin for the hazard (24fb84)

SITUATION After a product that just got an FDA warning letter, umbrella underlying-limit adequacy memo is what treaty pricing actuary can touch in a fleet with a new ELD vendor and rising frequency. Insurance Underwriting will live with Bind versus Restrict on this Core Commercial Lines file.

DECISION Treaty pricing actuary in a fleet with a new ELD vendor and rising frequency must choose Bind / Restrict / Decline / Hold using umbrella underlying-limit adequacy memo after a product that just got an FDA warning letter.

HYPOTHESES TO TEST 1. A product that just got an FDA warning letter is already priced into umbrella underlying-limit adequacy memo; treaty pricing actuary can take Bind on umbrella attachment is too thin inside a fleet with a new ELD vendor and rising frequency. 2. A product that just got an FDA warning letter is the event in umbrella underlying-limit adequacy memo that forces Restrict rather than Bind for this Core Commercial Lines file. 3. Umbrella underlying-limit adequacy memo shows a one-file miss after a product that just got an FDA warning letter, not a Insurance Underwriting program failure across a fleet with a new ELD vendor and rising frequency. 4. Umbrella attachment is too thin cannot be closed from umbrella underlying-limit adequacy memo after a product that just got an FDA warning letter; treaty pricing actuary should keep Hold in force.

ANALYSIS REQUIRED 1. Say whether a fleet with a new ELD vendor and rising frequency can bind, restrict, or decline from the file as it stands. 2. Test exposure, limits, and endorsement language in umbrella underlying-limit adequacy memo after a product that just got an FDA warning letter. 3. Flag any accumulation fact umbrella underlying-limit adequacy memo does not price. 4. For this Insurance Underwriting Core Commercial Lines file, read umbrella underlying-limit adequacy memo against a product that just got an FDA warning letter and write the one fact that would move umbrella attachment is too thin for treaty pricing actuary.

RECOMMENDATION Treaty pricing actuary should take Restrict on umbrella attachment is too thin unless umbrella underlying-limit adequacy memo after a product that just got an FDA warning letter already proves Bind for this Core Commercial Lines packet in a fleet with a new ELD vendor and rising frequency. Keep Decline live only while umbrella underlying-limit adequacy memo is missing the decision umbrella attachment is too thin turns on. The working test on umbrella underlying-limit adequacy memo is whether Say whether a fleet with a new ELD vendor and rising frequency can bind, restrict, or decl.

COMMAND RETURNS - Bottom-line Insurance Underwriting option on umbrella attachment is too thin, then the evidence in umbrella underlying-limit adequacy memo, then the action for treaty pricing actuary - Hypothesis scorecard against umbrella underlying-limit adequacy memo: supported / rejected / untestable - Missing page in umbrella underlying-limit adequacy memo after a product that just got an FDA warning letter, if any - Regulatory or exam hook Core Commercial Lines would cite